“Minimally Invasive Glaucoma Surgery (MIGS) Advancements”
One specific trend helping the growth of the glaucoma surgery market is the increasing adoption of Minimally Invasive Glaucoma Surgery (MIGS). MIGS offers significant advantages, including faster recovery times, reduced risk of complications, and less discomfort for patients compared to traditional glaucoma surgeries. This trend is driven by the growing demand for safer, more efficient treatment options. For instance, devices such as the iStent inject, which is used to reduce intraocular pressure in glaucoma patients, have seen widespread adoption. These procedures are being increasingly recommended as a preferred option by healthcare providers, contributing to the market's expansion as patient demand for less invasive solutions grows.
